Read More

FDA Commissioner suggests there is no reason for a DEA delay on rescheduling

On April 11, the U.S. Food and Drug Administration Commissioner Robert Califf testified to the House of Representatives Committee on Oversight and Accountability, causing many in the industry to speculate when and if the Drug and Enforcement Administration (DEA) will change the scheduling for cannabis. The most critical statement in …